Related by context. Frequent words. (Click for all words.) 66 refractory multiple myeloma 58 refractory peripheral T 58 HGS ETR1 58 relapsed multiple myeloma 57 PXD# 57 TELCYTA 57 FOLOTYN 56 BAY #-# 56 CoFactor 56 vandetanib 55 relapsed 55 valopicitabine 55 eltrombopag 55 pixantrone 55 FavId 55 chronic angina 55 perifosine 55 opioid induced constipation 54 diabetic neuropathic pain 54 Ceplene 54 post herpetic neuralgia 54 SEROQUEL XR 54 carfilzomib 54 Jevtana 54 Genasense 54 peginterferon 54 Marqibo 54 picoplatin 54 temsirolimus 54 TORISEL 54 Pixantrone 54 Phase 2a trial 54 tocilizumab 53 vinorelbine 53 Mylotarg 53 monotherapy 53 dose escalation 53 Taxotere ® 53 COPAXONE R 53 relapsing remitting multiple sclerosis 53 peginterferon alfa 2b 53 azacitidine 53 metastatic renal cell carcinoma 53 imetelstat 53 biologic therapy 53 Xcytrin 52 Phenoptin 52 bipolar depression 52 AP# [003] 52 Phase 2b study 52 palliation 52 ASA# 52 nalmefene 52 infliximab 52 pegylated interferon 52 clofarabine 52 palifosfamide 52 erlotinib 52 sorafenib 52 satraplatin 52 eculizumab 52 castration resistant prostate cancer 52 phase IIa 52 mitoxantrone 52 thiazolidinedione 52 cutaneous T cell 52 mg BID 51 oxaliplatin 51 IMGN# 51 RECIST criteria 51 ofatumumab 51 voreloxin 51 sustained virologic response 51 sunitinib 51 adalimumab 51 velaglucerase alfa 51 Torisel 51 Clolar 51 evaluable patients 51 FOLFIRI 51 endocrine therapy 50 Zerenex 50 plus ribavirin 50 Dacogen 50 chronic ITP 50 RG# [001] 50 pemetrexed 50 phase IIb 50 hepatic encephalopathy 50 TREANDA 50 myelodysplastic syndromes MDS 50 lupus nephritis 50 neoadjuvant chemotherapy 50 azathioprine 50 follicular non 50 LIALDA 50 Phase 2a clinical 50 dosing regimens 50 taxane 50 dasatinib 50 Phase Ib